Invention Grant
US08354416B2 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
失效
7,8-二氢吡啶并[2,3-d]嘧啶-4-基取代的化合物作为p38激酶的抑制剂
![7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase](/docs/US/2013-01-15/US08354416B2/abs.jpg.600x600.jpg)
- Patent Title: 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
- Patent Title (中): 7,8-二氢吡啶并[2,3-d]嘧啶-4-基取代的化合物作为p38激酶的抑制剂
-
Application No.: US12132793Application Date: 2008-06-04
-
Publication No.: US08354416B2Publication Date: 2013-01-15
- Inventor: James F. Callahan , Jeffrey C. Boehm , Anthony William James Cooper , Stefano Livia , Paul Bamborough , Neysa Nevins , Zehong Wan , Beth A. Norton , Xichen Lin
- Applicant: James F. Callahan , Jeffrey C. Boehm , Anthony William James Cooper , Stefano Livia , Paul Bamborough , Neysa Nevins , Zehong Wan , Beth A. Norton , Xichen Lin
- Applicant Address: GB Greenford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford, Middlesex
- Agent James P. Riek
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; A61P29/00 ; A61P9/10
![7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase](/abs-image/US/2013/01/15/US08354416B2/abs.jpg.150x150.jpg)
Abstract:
Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
Public/Granted literature
- US20090156597A1 Novel Compounds Public/Granted day:2009-06-18
Information query
